Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Policy Forum in DC in 2017

    With Renewed Optimism: A Patient Advisor’s Hopeful Perspective on Parkinson’s Research

    Kevin Kwok, a Parkinson’s advocate, wrote that PD drug development is like “cave exploration in the dark,” but now we have the lantern we need. Read more.
    Learn more
  • Common Questions from Our Webinar on Parkinson's Medications

    FDA approves new levodopa/carbidopa formulation for use in Parkinson’s

    The U.S. Food and Drug Administration (FDA) has approved a new medication for the treatment of Parkinson's disease. Crexont aims to offer patients improved symptom control and a better quality…
    Learn more
  • Spotlight on Parkinson's Research Progress at International Conference

    Non-profits in Neurodegenerative Space Publish Paper on Working Across Diseases

    Published paper highlighting collaboration across the neurodegenerative disease space. Authors detail efforts to bring together perspectives from stakeholders ranging from regulators to patients.
    Learn more
  • Research Podcast Cover

    Episode 20: Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor

    Dr. Paul Lingor discusses his work in this area to identify patterns of bioelements in CSF that could serve as Parkinson's disease biomarkers.
    Learn more
  • Research Podcast Cover

    Episode 19: Current and Emerging Imaging Biomarkers for Diagnosis and Prognosis of PD and Atypical Parkinsonism with Antonio Strafella

    Dr. Antonio Strafella discusses current practices for using molecular imaging biomarkers in research and in the clinic, the process of developing new biomarkers, as well as promising biomarkers that…
    Learn more
  • Getting Precise about Precision Medicine in Parkinson's

    FDA Reviewing Four New Parkinson's Medications in 2024

    Four new medications to treat Parkinson’s disease symptoms engaged with the review process by the U.S. Food and Drug Administration in 2024. Learn more.
    Learn more
  • President Speaks on High Price of Prescription Drugs

    What Does it Take to Get a Parkinson’s Drug Approved by the FDA?

    The Food and Drug Administration regularly reviews applications for drugs in development for Parkinson’s disease. Learn how the approval process works.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.